HNS (n = 6) | Smokers (n = 6) | COPD (n = 10) | |
---|---|---|---|
Sex, male/female | 1/5 | 3/3 | 5/5 |
Age, years | 36 (23–46) | 43 (35–53) | 62 (47–74) |
FEV1 | 2.97 (0.84) | 3.67 (0.88) | 1.96 (0.6) |
FEV1 predicted | 101.5 (13.1) | 107.0 (9.0) | 74.4 (21.8) |
FEV1/FVC, % | 81.0 (6.6) | 76.7 (5.2) | 56.2 (9.9) |
Pack year history | 0 | 15.9 | 47.1 |
ICS use, % | 0 | 0 | 70 |
LABA use, % | 0 | 0 | 50 |
LAMA use, % | 0 | 0 | 20 |
Current smokers, % | 0 | 100 | 70 |
LABA, long-acting β-agonist; LAMA, long-acting muscarinic antagonist; ICS, inhaled corticosteroid; FEV, forced expiratory volume; FVC, forced vital capacity.